Life begins with cells. 很好的关于细胞是生命基础的生物化学的教材


ANALYZE THE DATA
G. Johnson and colleagues have analyzed the kinase cascadein which MEKK2, a MAP kinase kinase kinase, participatesin mammalian cells. By a yeast two-hybrid screen (see Chap-ter 11), MEKK2 was found to bind MEK5, a MAP kinase kinase. To elucidate the signaling pathway transduced byMEKK2 in vivo, the following studies were performed inhuman embryonic kidney (HEK293) cells in culture.a.HEK293 cells were transfected with a plasmid encodingrecombinant, tagged MEKK2, along with a plasmid encod-ing MEK5 or a control vector that did not encode a protein(mock). Recombinant MEK5 was precipitated from the cellextract by absorption to a specific antibody. The immuno-precipitated material was then resolved by polyacrylamidegel electrophoresis, transferred to a membrane, and exam-ined by Western blotting with an antibody that recognizedtagged MEKK2. The results are shown in the figure below,part a. What information about the MEKK2 kinase cascadedo we learn from this experiment? Do the data in part a ofthe figure prove that MEKK2 activates MEK5, or vice versa?
k
(a)
MocMEK5
MEKK2
K5A
A
K2K2 + ME2 + M
EK5(b)
ME
K5
MEKMEKME
KKPhosphorylated ERK5ERK5
b.ERK5 is a MAP kinase previously shown to be activated
when phosphorylated by MEK5. When ERK5 is phospho-rylated by MEK5, its migration on a polyacrylamide gel is retarded. In the experiment shown in part b of the figure,HEK293 cells were transfected with a plasmid encodingERK5 along with plasmids encoding MEK5, MEKK2,MEKK2 and MEK5, or MEKK2 and MEK5AA. MEK5AA is a mutant, inactive version of MEK5 that functions as adominant-negative. Expression of MEK5AA in HEK293cells prevents signaling through active, endogenous MEK5.Lysates of transfected cells were analyzed by Western blot-ting with an antibody against recombinant ERK5. From thedata in part b of the figure, what can we conclude about therole of MEKK2 in the activation of ERK5? How do the dataobtained when cells are cotransfected with ERK5, MEKK2,and MEK5AA help to elucidate the order of participants inthis kinase cascade?
References
609
REFERENCES
TGF Receptors and the Direct Activation of Smads
Blobe, G., W. Schiemann, and H. Lodish. 2000. Role of trans-forming growth factor beta in human disease. N. Eng. J. Med.342:1350–1358.
Liu, X., Y. Sun, R. Weinberg, and H. Lodish. 2001. Ski/Sno andTGF-beta signaling. Cytokine Growth Factor Rev. 12:1–8.
Massagué, J. 2000. How cells read TGF-beta signals. NatureRev. Mol. Cell Biol. 1:169–178.
Massagué, J., S. Blain, and R. Lo. 2000. TGFbeta signaling ingrowth control, cancer, and heritable disorders. Cell103:295–309.
Moustakas, A., S. Souchelnytskyi, and C. Heldin. 2001. Smadregulation in TGF-beta signal transduction. J. Cell Sci.114:4359–4369.
Shi, Y. 2001. Structural insights on Smad function in TGFbetasignaling. Bioessays23:223–232.
ten Dijke, P., K. Miyazono, and C. Heldin. 2000. Signaling in-puts converge on nuclear effectors in TGF-beta signaling. TrendsBiochem. Sci. 25:64–70.
Wotton, D., and J. Massagué. 2001. Smad transcriptional core-pressors in TGF beta family signaling. Curr. Top. Microbiol. Im-munol. 254:45–164.
Cytokine Receptors and the JAK-STAT Pathway
Alexander, W. 2002. Suppressors of cytokine signalling (SOCS)in the immune system. Nature Rev. Immunol. 2:410–416.
Chatterjee-Kishore, M., F. van den Akker, and G. Stark. 2000.Association of STATs with relatives and friends. Trends Cell Biol.10:106–111.
Constantinescu, S. N., S. Ghaffari, and H. F. Lodish. 1999. Theerythropoietin receptor: structure, activation, and intracellular signaltransduction. Trends Endocrin. Metab.10:8–23.
Kile, B. T., et al. 2002. The SOCS box: a tale of destruction anddegradation. Trends Biochem. Sci.27:235–41.
Leonard, W. 2001. Role of Jak kinases and STATs in cytokinesignal transduction. Int. J. Hematol. 73:271–277.
Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional con-trol and biological impact. Nature Rev. Mol. Cell Biol.3:651–62.
Ozaki, K., and W. Leonard. 2002. Cytokine and cytokine receptorpleiotropy and redundancy. J. Biol. Chem. 277:29355–29358.
Ward, A., I. Touw, and A. Yoshimura. 2000. The Jak-Stat path-way in normal and perturbed hematopoiesis. Blood95:19–29.
Yasukawa, H., A. Sasaki, and A. Yoshimura. 2000. Negative reg-ulation of cytokine signaling pathways. Ann. Rev. Immunol. 18:43–164.
Receptor Tyrosine Kinases and Activation of Ras
Gschwind, A., et al. 2001. Cell communication networks: epi-dermal growth factor receptor transactivation as the paradigm forinterreceptor signal transmission. Oncogene20:1594–1600.
Harari, D., and Y. Yarden. 2000. Molecular mechanisms under-lying ErbB2/HER2 action in breast cancer. Oncogene19:6102–6114.
Hubbard, S. 1999. Structural analysis of receptor tyrosine ki-nases. Prog. Biophys. Mol. Biol. 71:343–358.
Huse, M., and J. Kuriyan. 2002. The conformational plasticityof protein kinases. Cell109:275–282.
Schlessinger, J. 2002. Ligand-induced, receptor-mediated dimer-ization and activation of EGF receptor. Cell110:669–672.
Shawver, L., D. Slamon, and A. Ullrich. 2002. Smart drugs: ty-rosine kinase inhibitors in cancer therapy. Cancer Cell1:117–123.
life's origins begins with the formation of the...以论证生命 氨基酸),以论证生命 ), 起源的化学进化...Further steps in the appearance of cells on the...
The story of life’s begins with the formation of the earth 生命起源于...cells would have included the origin of the genetic code; 最终导致活细胞的...
The story of life’s begins with the formation of the earth 生命起源于...cells would have included the origin of the genetic code; 最终导致活细胞的...
热门文档